Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Tilray closes merger with Aphria, expects $81M of synergies » 11:35
05/06/21
05/06
11:35
05/06/21
11:35
ACB

Aurora Cannabis

$8.48 /

-0.295 (-3.36%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$24.34 /

-1.09 (-4.29%)

, CRON

Cronos Group

$7.63 /

-0.26 (-3.30%)

, CANN

General Cannabis

/

+

, IGC

India Globalization Capital

$1.45 /

-0.095 (-6.15%)

, TCNNF

Trulieve Cannabis

$40.93 /

-0.44 (-1.06%)

, ZYNE

Zynerba

$3.98 /

-0.365 (-8.40%)

, ALEAF

Aleafia Health

/

+

, GTBIF

Green Thumb Industries

$31.60 /

+0.8227 (+2.67%)

, HITIF

High Tide

/

+

, INSHF

Inner Spirit Holdings

/

+

, SNDL

Sundial Growers

/

+

, APHA

Acquired by TLRY

$15.38 /

+ (+0.00%)

, TLRY

Tilray

$14.49 /

-1.42 (-8.93%)

In this week's "Rising…

ShowHide Related Items >><<
TLRY Tilray
$14.49 /

-1.42 (-8.93%)

TCNNF Trulieve Cannabis
$40.93 /

-0.44 (-1.06%)

SNDL Sundial Growers
/

+

HITIF High Tide
/

+

GTBIF Green Thumb Industries
$31.60 /

+0.8227 (+2.67%)

CTST CannTrust
/

+

CGC Canopy Growth
$24.34 /

-1.09 (-4.29%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

ALEAF Aleafia Health
/

+

ACB Aurora Cannabis
$8.48 /

-0.295 (-3.36%)

ACB Aurora Cannabis
$8.48 /

-0.295 (-3.36%)

04/28/21 BofA
Aurora Cannabis reinstated with a Neutral at BofA
04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/05/21 CIBC
Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
CVSI CV Sciences
/

+

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
CTST CannTrust
/

+

CGC Canopy Growth
$24.34 /

-1.09 (-4.29%)

04/28/21 BofA
Canopy Growth resumed with a Buy at BofA
04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
CRON Cronos Group
$7.63 /

-0.26 (-3.30%)

04/28/21 BofA
BofA reinstates Cronos Group at Underperform with $7.50 price target
04/28/21 BofA
Cronos Group reinitiated with an Underperform at BofA
CANN General Cannabis
/

+

01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
IGC India Globalization Capital
$1.45 /

-0.095 (-6.15%)

TCNNF Trulieve Cannabis
$40.93 /

-0.44 (-1.06%)

04/15/21 Cowen
Trulieve Cannabis initiated with an Outperform at Cowen
04/13/21 Canaccord
Trulieve Cannabis price target raised to C$90 from C$87 at Canaccord
03/25/21 Stifel
Trulieve Cannabis price target raised to C$118 from C$107 at Stifel
ZYNE Zynerba
$3.98 /

-0.365 (-8.40%)

05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
02/03/21 Ladenburg
Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg
ALEAF Aleafia Health
/

+

03/10/21 Cantor Fitzgerald
Aleafia Health initiated with a Neutral at Cantor Fitzgerald
GTBIF Green Thumb Industries
$31.60 /

+0.8227 (+2.67%)

03/29/21 Alliance Global Partners
NY cannabis bill 'big win' for Acreage and Curaleaf, says Alliance Global
03/18/21 Craig-Hallum
Green Thumb Industries price target raised to $60 from $55 at Craig-Hallum
03/18/21 Alliance Global Partners
Green Thumb price target raised to C$55 from C$50 at Alliance Global Partners
03/18/21 Piper Sandler
Green Thumb Industries price target raised to $40 from $35 at Piper Sandler
HITIF High Tide
/

+

INSHF Inner Spirit Holdings
/

+

SNDL Sundial Growers
/

+

03/19/21 Canaccord
Sundial Growers downgraded to Sell from Hold at Canaccord
03/10/21
Fly Intel: Top five analyst initiations
03/10/21 Cantor Fitzgerald
Sundial Growers initiated with a Neutral at Cantor Fitzgerald
03/10/21 Cantor Fitzgerald
Sundial Growers initiated with a Neutral at Cantor Fitzgerald
APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
TLRY Tilray
$14.49 /

-1.42 (-8.93%)

05/07/21 Jefferies
Jefferies double upgrades Tilray to Buy on 'perfect match' merger
05/07/21 Jefferies
Tilray resumed with a Buy from Underperform at Jefferies
05/06/21 Canaccord
Canaccord starts Tilray at Hold, says shares 'fully valued'
05/06/21
Fly Intel: Top five analyst initiations
ZYNE Zynerba
$3.98 /

-0.365 (-8.40%)

TLRY Tilray
$14.49 /

-1.42 (-8.93%)

TCNNF Trulieve Cannabis
$40.93 /

-0.44 (-1.06%)

CRON Cronos Group
$7.63 /

-0.26 (-3.30%)

CGC Canopy Growth
$24.34 /

-1.09 (-4.29%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

ALEAF Aleafia Health
/

+

ACB Aurora Cannabis
$8.48 /

-0.295 (-3.36%)

  • 22
    Jan
  • 11
    Nov
SNDL Sundial Growers
/

+

GTBIF Green Thumb Industries
$31.60 /

+0.8227 (+2.67%)

CTST CannTrust
/

+

CGC Canopy Growth
$24.34 /

-1.09 (-4.29%)

ACB Aurora Cannabis
$8.48 /

-0.295 (-3.36%)

SNDL Sundial Growers
/

+

INSHF Inner Spirit Holdings
/

+

GTBIF Green Thumb Industries
$31.60 /

+0.8227 (+2.67%)

ALEAF Aleafia Health
/

+

ACB Aurora Cannabis
$8.48 /

-0.295 (-3.36%)

ZYNE Zynerba
$3.98 /

-0.365 (-8.40%)

TLRY Tilray
$14.49 /

-1.42 (-8.93%)

SNDL Sundial Growers
/

+

IGC India Globalization Capital
$1.45 /

-0.095 (-6.15%)

CRON Cronos Group
$7.63 /

-0.26 (-3.30%)

CGC Canopy Growth
$24.34 /

-1.09 (-4.29%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

ACB Aurora Cannabis
$8.48 /

-0.295 (-3.36%)

Hot Stocks
Tilray closes merger with Aphria, expects $81M of synergies in 18 months » 15:51
05/03/21
05/03
15:51
05/03/21
15:51
TLRY

Tilray

$17.06 /

-1.29 (-7.03%)

, APHA

Acquired by TLRY

$15.38 /

+ (+0.00%)

Tilray (TLRY) and Aphria…

Tilray (TLRY) and Aphria (APHA) announced the completion of the previously announced business combination. The combined company will operate as Tilray and had a market cap of approximately $8.2 billion based on the closing stock prices on April 30, 2021. The Company's class 2 common stock will continue to trade on the Nasdaq Global Select Exchange under the ticker symbol "TLRY" and will commence trading on the Toronto Stock Exchange under the ticker symbol "TLRY" on May 5, 2021. As previously announced, each Aphria shareholder received 0.8381 of a Tilray Share for each Aphria common share held on April 30, 2021, the effective time of the transaction. Holders of Tilray Shares prior to the completion of the transaction continue to hold their Tilray Shares with no adjustment as a result of the transaction. The company expects to deliver approximately $81 million of annual pre-tax cost synergies within eighteen months and plans to achieve cost synergies in the key areas of cultivation and production, cannabis and product purchasing, sales, and marketing, and corporate expenses.

ShowHide Related Items >><<
TLRY Tilray
$17.06 /

-1.29 (-7.03%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

TLRY Tilray
$17.06 /

-1.29 (-7.03%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
TLRY Tilray
$17.06 /

-1.29 (-7.03%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

TLRY Tilray
$17.06 /

-1.29 (-7.03%)

TLRY Tilray
$17.06 /

-1.29 (-7.03%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

TLRY Tilray
$17.06 /

-1.29 (-7.03%)

APHA Acquired by TLRY
$15.38 /

+ (+0.00%)

Options
Two new option listings and four option delistings on May 3rd » 08:30
05/03/21
05/03
08:30
05/03/21
08:30
AGL

Agilon Health

$31.46 /

+0.165 (+0.53%)

, GTX

Garrett Motion

$5.51 /

+0.0085 (+0.15%)

, APHA

Aphria

$15.38 /

-0.07 (-0.45%)

, RNET

RigNet

$9.62 /

-0.18 (-1.84%)

, WDR

Waddell & Reed

$24.99 /

-0.005 (-0.02%)

New option listings for…

New option listings for May 3rd include Agilon Health inc (AGL) and Garrett Motion Inc (GTX). Option delistings effective May 3rd include Aphria (APHA), Garrett Motion Inc (GTXMQ), RigNet (RNET), and Waddell and Reed Financial (Class A Stock) (WDR).

ShowHide Related Items >><<
WDR Waddell & Reed
$24.99 /

-0.005 (-0.02%)

RNET RigNet
$9.62 /

-0.18 (-1.84%)

GTX Garrett Motion
$5.51 /

+0.0085 (+0.15%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

AGL Agilon Health
$31.46 /

+0.165 (+0.53%)

GTX Garrett Motion
$5.51 /

+0.0085 (+0.15%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
RNET RigNet
$9.62 /

-0.18 (-1.84%)

12/21/20 National Securities
RigNet downgraded to Neutral from Buy at National Securities
WDR Waddell & Reed
$24.99 /

-0.005 (-0.02%)

12/04/20 Morgan Stanley
Morgan Stanley upgrades Waddell & Reed to Equal Weight, assumes deal will close
12/04/20 Morgan Stanley
Waddell & Reed upgraded to Equal Weight from Underweight at Morgan Stanley
12/03/20 Evercore ISI
Waddell & Reed upgraded to In Line from Underperform at Evercore ISI
10/05/20 Jefferies
Trian involvement could by catalyst for 'beaten down' managers, says Jefferies
WDR Waddell & Reed
$24.99 /

-0.005 (-0.02%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

  • 15
    Apr
APHA Aphria
$15.38 /

-0.07 (-0.45%)

WDR Waddell & Reed
$24.99 /

-0.005 (-0.02%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

AGL Agilon Health
$31.46 /

+0.165 (+0.53%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

Periodicals
Legalized marijuana will be big win for U.S. pot stocks, Barron's says » 10:11
05/01/21
05/01
10:11
05/01/21
10:11
CURLF

Curaleaf

$14.10 /

+0.79 (+5.94%)

, GTBIF

Green Thumb Industries

$32.00 /

+ (+0.00%)

, TCNNF

Trulieve Cannabis

$41.59 /

+2.2375 (+5.69%)

, CRLBF

Cresco Labs

$13.00 /

+0.75 (+6.12%)

, CGC

Canopy Growth

$26.96 /

-0.43 (-1.57%)

, TLRY

Tilray

$18.35 /

-0.32 (-1.71%)

, APHA

Aphria

$15.38 /

-0.07 (-0.45%)

American cannabis…

American cannabis companies-such as Curaleaf (CURLF), Green Thumb Industries (GTBIF), Trulieve Cannabis (TCNNF), and Cresco Labs (CRLBF)-have licenses to operate in states that allow weed under their laws, but the industry has been bedeviled by marijuana's illegality under U.S. federal law, Max Cherney and Connor Smith write in this week's edition of Barron's. Many investors know only Canadian producers such as Canopy Growth (CGC), Tilray (TLRY), or Aphria (APHA), whose wholly legal Canadian activities let them list on the Nasdaq, the authors note. Now, events are breaking in favor of the American operators, with the House of Representatives passing a bill by a 3-to-1 margin that would allow the pot industry to use the federally regulated banking system, and New York, Virginia, and New Mexico recently joining the 13 states that have allowed recreational sales to adults. Over time, recreational sales will probably come to the 20 states that now allow sale by prescription, the publication adds, pointing out that could spur the remaining state holdouts to fall in line, if federal legalization doesn't happen first. Reference Link

ShowHide Related Items >><<
TLRY Tilray
$18.35 /

-0.32 (-1.71%)

TCNNF Trulieve Cannabis
$41.59 /

+2.2375 (+5.69%)

GTBIF Green Thumb Industries
$32.00 /

+ (+0.00%)

CURLF Curaleaf
$14.10 /

+0.79 (+5.94%)

CRLBF Cresco Labs
$13.00 /

+0.75 (+6.12%)

CGC Canopy Growth
$26.96 /

-0.43 (-1.57%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

CURLF Curaleaf
$14.10 /

+0.79 (+5.94%)

03/29/21 Alliance Global Partners
NY cannabis bill 'big win' for Acreage and Curaleaf, says Alliance Global
03/11/21 Canaccord
Curaleaf price target raised to C$24 from C$23.50 at Canaccord
03/08/21 BTIG
Curaleaf initiated with a Buy at BTIG
02/25/21 Stifel
Curaleaf price target raised to C$32.25 from C$23 at Stifel
GTBIF Green Thumb Industries
$32.00 /

+ (+0.00%)

03/18/21 Craig-Hallum
Green Thumb Industries price target raised to $60 from $55 at Craig-Hallum
03/18/21 Alliance Global Partners
Green Thumb price target raised to C$55 from C$50 at Alliance Global Partners
03/18/21 Piper Sandler
Green Thumb Industries price target raised to $40 from $35 at Piper Sandler
TCNNF Trulieve Cannabis
$41.59 /

+2.2375 (+5.69%)

04/15/21 Cowen
Trulieve Cannabis initiated with an Outperform at Cowen
04/13/21 Canaccord
Trulieve Cannabis price target raised to C$90 from C$87 at Canaccord
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/25/21 Stifel
Trulieve Cannabis price target raised to C$118 from C$107 at Stifel
CRLBF Cresco Labs
$13.00 /

+0.75 (+6.12%)

03/26/21 Stifel
Cresco Labs price target lowered to C$34 from C$36 at Stifel
03/19/21 Stifel
Cresco Labs price target raised to C$36 from C$33.50 at Stifel
03/08/21 BTIG
Cresco Labs initiated with a Buy at BTIG
CGC Canopy Growth
$26.96 /

-0.43 (-1.57%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/28/21 BofA
Canopy Growth resumed with a Buy at BofA
04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
TLRY Tilray
$18.35 /

-0.32 (-1.71%)

04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
APHA Aphria
$15.38 /

-0.07 (-0.45%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
TLRY Tilray
$18.35 /

-0.32 (-1.71%)

TCNNF Trulieve Cannabis
$41.59 /

+2.2375 (+5.69%)

CURLF Curaleaf
$14.10 /

+0.79 (+5.94%)

CGC Canopy Growth
$26.96 /

-0.43 (-1.57%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

TCNNF Trulieve Cannabis
$41.59 /

+2.2375 (+5.69%)

GTBIF Green Thumb Industries
$32.00 /

+ (+0.00%)

CURLF Curaleaf
$14.10 /

+0.79 (+5.94%)

TCNNF Trulieve Cannabis
$41.59 /

+2.2375 (+5.69%)

GTBIF Green Thumb Industries
$32.00 /

+ (+0.00%)

CURLF Curaleaf
$14.10 /

+0.79 (+5.94%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

TLRY Tilray
$18.35 /

-0.32 (-1.71%)

CGC Canopy Growth
$26.96 /

-0.43 (-1.57%)

APHA Aphria
$15.38 /

-0.07 (-0.45%)

On The Fly
Rising High: An exclusive talk with multi-state operator Body and Mind » 12:32
04/29/21
04/29
12:32
04/29/21
12:32
ZYNE

Zynerba

$4.43 /

-0.2 (-4.32%)

, TCNNF

Trulieve Cannabis

$40.57 /

+0.69 (+1.73%)

, TLRY

Tilray

$17.74 /

-1.6 (-8.27%)

, IGC

India Globalization Capital

$1.58 /

-0.03 (-1.86%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$8.03 /

-0.385 (-4.58%)

, CGC

Canopy Growth

$26.77 /

-1.39 (-4.94%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$8.72 /

-0.33 (-3.65%)

, APHA

Aphria

$14.85 /

-1.155 (-7.22%)

, BMMJ

Body and Mind

/

+

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
$4.43 /

-0.2 (-4.32%)

TLRY Tilray
$17.74 /

-1.6 (-8.27%)

CTST CannTrust
/

+

CGC Canopy Growth
$26.77 /

-1.39 (-4.94%)

APHA Aphria
$14.85 /

-1.155 (-7.22%)

ZYNE Zynerba
$4.43 /

-0.2 (-4.32%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
02/03/21 Ladenburg
Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
TCNNF Trulieve Cannabis
$40.57 /

+0.69 (+1.73%)

04/15/21 Cowen
Trulieve Cannabis initiated with an Outperform at Cowen
04/13/21 Canaccord
Trulieve Cannabis price target raised to C$90 from C$87 at Canaccord
03/25/21 Stifel
Trulieve Cannabis price target raised to C$118 from C$107 at Stifel
TLRY Tilray
$17.74 /

-1.6 (-8.27%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
IGC India Globalization Capital
$1.58 /

-0.03 (-1.86%)

01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
CANN General Cannabis
/

+

CRON Cronos Group
$8.03 /

-0.385 (-4.58%)

04/28/21 BofA
BofA reinstates Cronos Group at Underperform with $7.50 price target
04/28/21 BofA
Cronos Group reinitiated with an Underperform at BofA
CGC Canopy Growth
$26.77 /

-1.39 (-4.94%)

04/28/21 BofA
Canopy Growth resumed with a Buy at BofA
04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
CTST CannTrust
/

+

CVSI CV Sciences
/

+

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
ACB Aurora Cannabis
$8.72 /

-0.33 (-3.65%)

04/28/21 BofA
Aurora Cannabis reinstated with a Neutral at BofA
04/05/21 CIBC
Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
APHA Aphria
$14.85 /

-1.155 (-7.22%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
BMMJ Body and Mind
/

+

ZYNE Zynerba
$4.43 /

-0.2 (-4.32%)

TLRY Tilray
$17.74 /

-1.6 (-8.27%)

TCNNF Trulieve Cannabis
$40.57 /

+0.69 (+1.73%)

CRON Cronos Group
$8.03 /

-0.385 (-4.58%)

CGC Canopy Growth
$26.77 /

-1.39 (-4.94%)

APHA Aphria
$14.85 /

-1.155 (-7.22%)

ACB Aurora Cannabis
$8.72 /

-0.33 (-3.65%)

  • 22
    Jan
  • 11
    Nov
ZYNE Zynerba
$4.43 /

-0.2 (-4.32%)

CTST CannTrust
/

+

ZYNE Zynerba
$4.43 /

-0.2 (-4.32%)

CANN General Cannabis
/

+

APHA Aphria
$14.85 /

-1.155 (-7.22%)

ZYNE Zynerba
$4.43 /

-0.2 (-4.32%)

TLRY Tilray
$17.74 /

-1.6 (-8.27%)

IGC India Globalization Capital
$1.58 /

-0.03 (-1.86%)

CRON Cronos Group
$8.03 /

-0.385 (-4.58%)

CGC Canopy Growth
$26.77 /

-1.39 (-4.94%)

APHA Aphria
$14.85 /

-1.155 (-7.22%)

ACB Aurora Cannabis
$8.72 /

-0.33 (-3.65%)

On The Fly
Rising High: An exclusive talk with retail-focused cannabis company High Tide » 12:26
04/22/21
04/22
12:26
04/22/21
12:26
HITIF

High Tide

/

+

, APHA

Aphria

$13.98 /

+0.125 (+0.90%)

, ACB

Aurora Cannabis

$8.18 /

-0.015 (-0.18%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$27.15 /

-0.02 (-0.07%)

, CRON

Cronos Group

$8.16 /

+0.07 (+0.87%)

, CANN

General Cannabis

/

+

, IGC

India Globalization Capital

$1.53 /

+0.07 (+4.79%)

, TLRY

Tilray

$16.87 /

+0.07 (+0.42%)

, TCNNF

Trulieve Cannabis

$38.20 /

+2.77 (+7.82%)

, ZYNE

Zynerba

$4.15 /

-0.23 (-5.25%)

In this edition of…

ShowHide Related Items >><<
TLRY Tilray
$16.87 /

+0.07 (+0.42%)

CTST CannTrust
/

+

CGC Canopy Growth
$27.15 /

-0.02 (-0.07%)

APHA Aphria
$13.98 /

+0.125 (+0.90%)

ACB Aurora Cannabis
$8.18 /

-0.015 (-0.18%)

HITIF High Tide
/

+

APHA Aphria
$13.98 /

+0.125 (+0.90%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
ACB Aurora Cannabis
$8.18 /

-0.015 (-0.18%)

04/05/21 CIBC
Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/16/21 CIBC
Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC
02/16/21 GLJ Research
Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research
CVSI CV Sciences
/

+

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
CTST CannTrust
/

+

CGC Canopy Growth
$27.15 /

-0.02 (-0.07%)

04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
04/09/21 Cantor Fitzgerald
Canopy Growth price target lowered to C$35 from C$62 at Cantor Fitzgerald
04/08/21 Alliance Global Partners
Canopy Growth price target lowered to C$40 from C$60 at Alliance Global Partners
CRON Cronos Group
$8.16 /

+0.07 (+0.87%)

03/01/21 Canaccord
Cronos Group price target raised to C$7.50 from C$6.50 at Canaccord
02/22/21 CIBC
Cronos Group downgraded to Neutral from Outperformer at CIBC
CANN General Cannabis
/

+

01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
IGC India Globalization Capital
$1.53 /

+0.07 (+4.79%)

TLRY Tilray
$16.87 /

+0.07 (+0.42%)

04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
02/18/21
Fly Intel: Top five analyst downgrades
TCNNF Trulieve Cannabis
$38.20 /

+2.77 (+7.82%)

04/15/21 Cowen
Trulieve Cannabis initiated with an Outperform at Cowen
04/13/21 Canaccord
Trulieve Cannabis price target raised to C$90 from C$87 at Canaccord
03/25/21 Stifel
Trulieve Cannabis price target raised to C$118 from C$107 at Stifel
ZYNE Zynerba
$4.15 /

-0.23 (-5.25%)

03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
02/03/21 Ladenburg
Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg
ZYNE Zynerba
$4.15 /

-0.23 (-5.25%)

TLRY Tilray
$16.87 /

+0.07 (+0.42%)

TCNNF Trulieve Cannabis
$38.20 /

+2.77 (+7.82%)

CRON Cronos Group
$8.16 /

+0.07 (+0.87%)

CGC Canopy Growth
$27.15 /

-0.02 (-0.07%)

APHA Aphria
$13.98 /

+0.125 (+0.90%)

ACB Aurora Cannabis
$8.18 /

-0.015 (-0.18%)

  • 22
    Jan
  • 11
    Nov
CTST CannTrust
/

+

APHA Aphria
$13.98 /

+0.125 (+0.90%)

HITIF High Tide
/

+

CGC Canopy Growth
$27.15 /

-0.02 (-0.07%)

CANN General Cannabis
/

+

APHA Aphria
$13.98 /

+0.125 (+0.90%)

ACB Aurora Cannabis
$8.18 /

-0.015 (-0.18%)

ZYNE Zynerba
$4.15 /

-0.23 (-5.25%)

TLRY Tilray
$16.87 /

+0.07 (+0.42%)

IGC India Globalization Capital
$1.53 /

+0.07 (+4.79%)

CRON Cronos Group
$8.16 /

+0.07 (+0.87%)

CGC Canopy Growth
$27.15 /

-0.02 (-0.07%)

APHA Aphria
$13.98 /

+0.125 (+0.90%)

ACB Aurora Cannabis
$8.18 /

-0.015 (-0.18%)

On The Fly
Rising High: An exclusive talk with multi-country operator IM Cannabis » 12:14
04/15/21
04/15
12:14
04/15/21
12:14
ZYNE

Zynerba

$4.12 /

-0.205 (-4.74%)

, TCNNF

Trulieve Cannabis

$41.31 /

+0.71 (+1.75%)

, TLRY

Tilray

$17.66 /

+0.27 (+1.55%)

, IGC

India Globalization Capital

$1.54 /

-0.055 (-3.45%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$8.25 /

+0.015 (+0.18%)

, CGC

Canopy Growth

$27.79 /

+0.04 (+0.14%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$7.95 /

-0.03 (-0.38%)

, APHA

Aphria

$14.07 /

-0.14 (-0.99%)

, MYMMF

MYM Nutraceuticals

/

+

, IMCC

IM Cannabis

$5.75 /

-0.15 (-2.54%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
$4.12 /

-0.205 (-4.74%)

TLRY Tilray
$17.66 /

+0.27 (+1.55%)

IMCC IM Cannabis
$5.75 /

-0.15 (-2.54%)

CTST CannTrust
/

+

CGC Canopy Growth
$27.79 /

+0.04 (+0.14%)

APHA Aphria
$14.07 /

-0.14 (-0.99%)

ZYNE Zynerba
$4.12 /

-0.205 (-4.74%)

03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
02/03/21 Ladenburg
Jazz deal for GW 'spotlights' value of Zynerba CBD products, says Ladenburg
02/02/21 Craig-Hallum
Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
TCNNF Trulieve Cannabis
$41.31 /

+0.71 (+1.75%)

04/15/21 Cowen
Trulieve Cannabis initiated with an Outperform at Cowen
04/13/21 Canaccord
Trulieve Cannabis price target raised to C$90 from C$87 at Canaccord
03/25/21 Stifel
Trulieve Cannabis price target raised to C$118 from C$107 at Stifel
TLRY Tilray
$17.66 /

+0.27 (+1.55%)

04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
02/18/21
Fly Intel: Top five analyst downgrades
IGC India Globalization Capital
$1.54 /

-0.055 (-3.45%)

01/29/21 Stifel
'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
CANN General Cannabis
/

+

CRON Cronos Group
$8.25 /

+0.015 (+0.18%)

03/01/21 Canaccord
Cronos Group price target raised to C$7.50 from C$6.50 at Canaccord
02/22/21 CIBC
Cronos Group downgraded to Neutral from Outperformer at CIBC
CGC Canopy Growth
$27.79 /

+0.04 (+0.14%)

04/12/21 Wolfe Research
Constellation Brands initiated with an Outperform at Wolfe Research
04/09/21 Stifel
Supreme Cannabis downgraded to Sell from Buy at Stifel
04/09/21 Cantor Fitzgerald
Canopy Growth price target lowered to C$35 from C$62 at Cantor Fitzgerald
04/08/21 Alliance Global Partners
Canopy Growth price target lowered to C$40 from C$60 at Alliance Global Partners
CTST CannTrust
/

+

CVSI CV Sciences
/

+

03/19/21 Piper Sandler
CV Sciences downgraded to Neutral on 'modest' growth at Piper Sandler
03/18/21 Piper Sandler
CV Sciences downgraded to Neutral from Overweight at Piper Sandler
ACB Aurora Cannabis
$7.95 /

-0.03 (-0.38%)

04/05/21 CIBC
Aurora Cannabis price target lowered to C$15 from C$18.50 at CIBC
02/16/21 CIBC
Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC
02/16/21 GLJ Research
Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research
APHA Aphria
$14.07 /

-0.14 (-0.99%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
MYMMF MYM Nutraceuticals
/

+

IMCC IM Cannabis
$5.75 /

-0.15 (-2.54%)

ZYNE Zynerba
$4.12 /

-0.205 (-4.74%)

TLRY Tilray
$17.66 /

+0.27 (+1.55%)

TCNNF Trulieve Cannabis
$41.31 /

+0.71 (+1.75%)

CRON Cronos Group
$8.25 /

+0.015 (+0.18%)

CGC Canopy Growth
$27.79 /

+0.04 (+0.14%)

APHA Aphria
$14.07 /

-0.14 (-0.99%)

ACB Aurora Cannabis
$7.95 /

-0.03 (-0.38%)

  • 22
    Jan
  • 11
    Nov
ZYNE Zynerba
$4.12 /

-0.205 (-4.74%)

CTST CannTrust
/

+

ZYNE Zynerba
$4.12 /

-0.205 (-4.74%)

IMCC IM Cannabis
$5.75 /

-0.15 (-2.54%)

CGC Canopy Growth
$27.79 /

+0.04 (+0.14%)

CANN General Cannabis
/

+

APHA Aphria
$14.07 /

-0.14 (-0.99%)

ZYNE Zynerba
$4.12 /

-0.205 (-4.74%)

TLRY Tilray
$17.66 /

+0.27 (+1.55%)

IGC India Globalization Capital
$1.54 /

-0.055 (-3.45%)

CRON Cronos Group
$8.25 /

+0.015 (+0.18%)

CGC Canopy Growth
$27.79 /

+0.04 (+0.14%)

APHA Aphria
$14.07 /

-0.14 (-0.99%)

ACB Aurora Cannabis
$7.95 /

-0.03 (-0.38%)

Hot Stocks
Aphria shareholders approve merger with Tilray » 07:08
04/15/21
04/15
07:08
04/15/21
07:08
APHA

Aphria

$14.21 /

-0.65 (-4.37%)

, TLRY

Tilray

$17.39 /

-0.93 (-5.08%)

Aphria's (APHA)…

Aphria's (APHA) shareholders at the special meeting of Aphria Shareholders approved the previously announced arrangement under the Business Corporations Act pursuant to which, among other things, Tilray (TLRY) will acquire all of the issued and outstanding Aphria Shares. Pursuant to the arrangement, the Aphria Shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria Share held, while holders of Tilray Shares will continue to hold their Tilray Shares with no adjustment to their holdings. Of the total Aphria Shares voted, 99.38% voted for the arrangement. Closing of the Arrangement remains subject to certain customary closing conditions, including court approval and the approval of Tilray Stockholders.

ShowHide Related Items >><<
TLRY Tilray
$17.39 /

-0.93 (-5.08%)

APHA Aphria
$14.21 /

-0.65 (-4.37%)

APHA Aphria
$14.21 /

-0.65 (-4.37%)

04/13/21 CIBC
Aphria price target lowered to C$23 from C$28 at CIBC
04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
TLRY Tilray
$17.39 /

-0.93 (-5.08%)

04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/18/21
Fly Intel: Top five analyst downgrades
TLRY Tilray
$17.39 /

-0.93 (-5.08%)

APHA Aphria
$14.21 /

-0.65 (-4.37%)

APHA Aphria
$14.21 /

-0.65 (-4.37%)

TLRY Tilray
$17.39 /

-0.93 (-5.08%)

APHA Aphria
$14.21 /

-0.65 (-4.37%)

TLRY Tilray
$17.39 /

-0.93 (-5.08%)

APHA Aphria
$14.21 /

-0.65 (-4.37%)

Recommendations
Aphria price target lowered to C$23 from C$28 at CIBC » 10:58
04/13/21
04/13
10:58
04/13/21
10:58
APHA

Acquired by TLRY

$14.78 /

+0.85 (+6.10%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo lowered the firm's price target on Aphria to C$23 from C$28 and keeps an Outperformer rating on the shares.

ShowHide Related Items >><<
APHA Acquired by TLRY
$14.78 /

+0.85 (+6.10%)

APHA Acquired by TLRY
$14.78 /

+0.85 (+6.10%)

04/13/21
Fly Intel: Top five analyst downgrades
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
04/12/21 Alliance Global Partners
Alliance Global trims Aphria price target to C$24, says long-term view intact
APHA Acquired by TLRY
$14.78 /

+0.85 (+6.10%)

APHA Acquired by TLRY
$14.78 /

+0.85 (+6.10%)

APHA Acquired by TLRY
$14.78 /

+0.85 (+6.10%)

APHA Acquired by TLRY
$14.78 /

+0.85 (+6.10%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:55
04/13/21
04/13
09:55
04/13/21
09:55
LHDX

Lucira Health

$8.95 /

-1.92 (-17.66%)

, APHA

Acquired by TLRY

$13.79 /

-0.14 (-1.01%)

, EH

Ehang

$27.65 /

-1.52 (-5.21%)

, GLNG

Golar LNG

$9.44 /

-0.305 (-3.13%)

, LMNX

Luminex

$36.98 /

-0.05 (-0.14%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lucira Health (LHDX) downgraded to Underperform from Buy at BofA with analyst Derik de Bruin saying the company's preliminary Q1 revenue guidance was well short of his estimate of $12.5M, and the discussions with the management suggested that the miss was due to a lack of demand for the company's prescription at home / point-of-care test for COVID-19. 2. Aphria (APHA) downgraded to Hold from Speculative Buy at Canaccord with analyst Matt Bottomley saying the company reported fiscal Q3 financial results that came in below expectations and noted sizable headwinds related to COVID-19 lockdown protocols, decreased pricing and the decision of most provincial buyers to lower their overall inventory levels. 3. Ehang (EH) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Tim Hsiao saying while EHang has an early-mover advantage, qualified products, and established global partnerships in the passenger-grade autonomous aerial vehicles market, Hsiao thinks the "tipping point of industry demand and EHang's operational breakthroughs will likely hinge on global regulatory approvals." 4. Golar LNG (GLNG) downgraded to Underperform from Buy at BofA with analyst Ken Hoexter arguing that Iain Ross' resignation as CEO, which marks Golar's sixth CEO in 10 years, highlights the difficulty in creating a new strategic direction for the company. 5. Luminex (LMNX) downgraded to Neutral from Buy at BTIG with analyst Sung Nam saying while the offer price "seems quite favorable" for DiaSorin, there is scarcity of potential acquirers that could maximize value across all of Luminex's businesses and product portfolio. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
LMNX Luminex
$36.98 /

-0.05 (-0.14%)

LHDX Lucira Health
$8.95 /

-1.92 (-17.66%)

GLNG Golar LNG
$9.44 /

-0.305 (-3.13%)

EH Ehang
$27.65 /

-1.52 (-5.21%)

APHA Acquired by TLRY
$13.79 /

-0.14 (-1.01%)

LHDX Lucira Health
$8.95 /

-1.92 (-17.66%)

04/13/21 BofA
Lucira Health downgraded to Underperform from Buy at BofA
04/13/21 BofA
Lucira Health downgraded to Underperform from Buy at BofA
03/02/21
Lucira Health initiated with an Outperform at LifeSci Capital
03/02/21 William Blair
Lucira Health initiated with an Outperform at William Blair
APHA Acquired by TLRY
$13.79 /

-0.14 (-1.01%)

04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
04/12/21 Alliance Global Partners
Alliance Global trims Aphria price target to C$24, says long-term view intact
04/08/21 Alliance Global Partners
Aphria price target raised to $26 from $20 at Alliance Global Partners
EH Ehang
$27.65 /

-1.52 (-5.21%)

04/13/21 Morgan Stanley
Morgan Stanley cuts Ehang to Equal Weight on regulatory, competitive uncertainty
04/13/21 Morgan Stanley
Ehang downgraded to Equal Weight from Overweight at Morgan Stanley
GLNG Golar LNG
$9.44 /

-0.305 (-3.13%)

04/13/21 BofA
Golar LNG downgraded to Underperform from Buy at BofA
03/01/21 Citi
Golar LNG resumed with a Neutral at Citi
01/29/21 Jefferies
Golar LNG price target raised to $17 from $15 at Jefferies
01/14/21 B. Riley
Golar LNG price target raised to $20.50 from $13 at B. Riley Securities
LMNX Luminex
$36.98 /

-0.05 (-0.14%)

04/13/21 Piper Sandler
Luminex downgraded to Neutral from Overweight at Piper Sandler
04/13/21 BTIG
Luminex downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
Luminex upgraded to Neutral from Underweight at JPMorgan
02/18/21 Piper Sandler
Luminex shares are undervalued, says Piper Sandler
LMNX Luminex
$36.98 /

-0.05 (-0.14%)

LHDX Lucira Health
$8.95 /

-1.92 (-17.66%)

GLNG Golar LNG
$9.44 /

-0.305 (-3.13%)

APHA Acquired by TLRY
$13.79 /

-0.14 (-1.01%)

  • 05
    Feb
  • 03
    Dec
LMNX Luminex
$36.98 /

-0.05 (-0.14%)

EH Ehang
$27.65 /

-1.52 (-5.21%)

APHA Acquired by TLRY
$13.79 /

-0.14 (-1.01%)

LMNX Luminex
$36.98 /

-0.05 (-0.14%)

LHDX Lucira Health
$8.95 /

-1.92 (-17.66%)

GLNG Golar LNG
$9.44 /

-0.305 (-3.13%)

EH Ehang
$27.65 /

-1.52 (-5.21%)

APHA Acquired by TLRY
$13.79 /

-0.14 (-1.01%)

EH Ehang
$27.65 /

-1.52 (-5.21%)

APHA Acquired by TLRY
$13.79 /

-0.14 (-1.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.